Medy-Tox Statistics

Total Valuation

Medy-Tox has a market cap or net worth of KRW 834.68 billion. The enterprise value is 893.85 billion.

Market Cap	834.68B
Enterprise Value	893.85B

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	Sep 27, 2024

Share Statistics

Medy-Tox has 6.73 million shares outstanding. The number of shares has decreased by -9.89% in one year.

Current Share Class	n/a
Shares Outstanding	6.73M
Shares Change (YoY)	-9.89%
Shares Change (QoQ)	-1.14%
Owned by Insiders (%)	19.80%
Owned by Institutions (%)	10.24%
Float	4.96M

Valuation Ratios

The trailing PE ratio is 77.06 and the forward PE ratio is 18.66.

PE Ratio	77.06
Forward PE	18.66
PS Ratio	3.42
PB Ratio	1.69
P/TBV Ratio	1.71
P/FCF Ratio	71.70
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.54, with an EV/FCF ratio of 76.79.

EV / Earnings	83.33
EV / Sales	3.70
EV / EBITDA	20.54
EV / EBIT	37.24
EV / FCF	76.79

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.16.

Current Ratio	1.35
Quick Ratio	0.74
Debt / Equity	0.16
Debt / EBITDA	1.97
Debt / FCF	7.00
Interest Coverage	9.36

Financial Efficiency

Return on equity (ROE) is 2.34% and return on invested capital (ROIC) is 2.37%.

Return on Equity (ROE)	2.34%
Return on Assets (ROA)	2.20%
Return on Capital (ROIC)	2.37%
Revenue Per Employee	334.88M
Profits Per Employee	14.88M
Employee Count	721
Asset Turnover	0.39
Inventory Turnover	1.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.79%
50-Day Moving Average	145,906.00
200-Day Moving Average	154,411.00
Relative Strength Index (RSI)	41.45
Average Volume (20 Days)	69,718

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medy-Tox had revenue of KRW 241.45 billion and earned 10.73 billion in profits. Earnings per share was 1,609.18.

Revenue	241.45B
Gross Profit	144.87B
Operating Income	21.83B
Pretax Income	13.43B
Net Income	10.73B
EBITDA	41.35B
EBIT	21.83B
Earnings Per Share (EPS)	1,609.18

Full Income Statement

Balance Sheet

The company has 27.70 billion in cash and 81.49 billion in debt, giving a net cash position of -53.79 billion or -7,990.85 per share.

Cash & Cash Equivalents	27.70B
Total Debt	81.49B
Net Cash	-53.79B
Net Cash Per Share	-7,990.85
Equity (Book Value)	498.58B
Book Value Per Share	73,269.88
Working Capital	42.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.04 billion and capital expenditures -8.40 billion, giving a free cash flow of 11.64 billion.

Operating Cash Flow	20.04B
Capital Expenditures	-8.40B
Free Cash Flow	11.64B
FCF Per Share	1,729.34

Full Cash Flow Statement

Margins

Gross margin is 60.00%, with operating and profit margins of 9.04% and 4.85%.

Gross Margin	60.00%
Operating Margin	9.04%
Pretax Margin	5.56%
Profit Margin	4.85%
EBITDA Margin	17.12%
EBIT Margin	9.04%
FCF Margin	4.82%

Dividends & Yields

This stock pays an annual dividend of 1,100.00, which amounts to a dividend yield of 0.89%.

Dividend Per Share	1,100.00
Dividend Yield	0.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	71.97%
Buyback Yield	9.89%
Shareholder Yield	10.78%
Earnings Yield	1.30%
FCF Yield	1.39%

Dividend Details

Stock Splits

The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.05.

Last Split Date	Dec 28, 2022
Split Type	Forward
Split Ratio	1.05

Scores

Medy-Tox has an Altman Z-Score of 7.23.

Altman Z-Score	7.23
Piotroski F-Score	n/a